Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

<p>Changes of cell types based on (a) MCP-Counter and (b) Danaher module with post- vs pre-treatment samples. All tests were performed by non-parametric Wilcoxon test.</p>

Saved in:
Bibliographic Details
Main Author: Tom Wei-Wu Chen (15053003) (author)
Other Authors: Chia-Lang Hsu (11929719) (author), Ruey-Long Hong (15053006) (author), Jen-Chieh Lee (14954275) (author), Koping Chang (15053009) (author), Chih-Wei Yu (15053012) (author), San-Chi Chen (15050106) (author), Jhe-Cyuan Guo (15053015) (author), Mei-Lu Chen (15053018) (author), Meng-Chi Hsu (15053021) (author), Ting-Fang Kung (15053024) (author), Ann-Lii Cheng (15045786) (author), Chueh-Chuan Yen (15053027) (author)
Published: 2025
Subjects:
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Sarcomas
Soft-tissue sarcoma
Translational Research
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<p>Changes of cell types based on (a) MCP-Counter and (b) Danaher module with post- vs pre-treatment samples. All tests were performed by non-parametric Wilcoxon test.</p>

Similar Items